COVAXIN

Around 50 million doses of Bharat Biotech manufactured Covid-19 vaccine, Covaxin lying with the company is set to expire early next year as there are no takers owing to poor demand, the company sources informed PTI. Covid Vaccine: Around 5…
Read More...

Travellers who have taken both doses of Bharat Biotech's Covid-19 vaccine Covaxin will be allowed to enter the US from November 8. This comes a day after Covaxin gets emergency use approval from World Health Organisation (WHO). Over…
Read More...

Expert panel of the Central Drug Authority has recommended granting emergency use authorisation to Bharat Biotech's Covaxin for children in the 2 to 18 years age group with certain conditions. With this, Covaxin becomes the first…
Read More...

New Delhi: The Drug Controller General of India (DGCI) on Thursday gave permission to Bharat Biotech to conduct clinical trials of its Covid-19 vaccines Covaxin on children belonging to the age group of 2 to 18 years. Bharat Biotech…
Read More...

New Delhi: Following the Govt of India directives, Bharat Biotech announce the prices of COVAXIN vaccines - Rs 600 per dose for state hospitals and Rs 1,200 per dose for private hospitals. Covid-19 continues to affect Indians as people…
Read More...

New Delhi: India on Tuesday confirmed that it will begin the export of COVID-19 vaccines from January 20 (Wednesday) with the first tranche being gifted to six neighbours. These countries are Nepal, Bangladesh, Myanmar, Bhutan, Maldives,…
Read More...

New Delhi: The Central Government has asked Bharat Biotech to supply around 55 lakh doses at 12 centres before 14 January, the report said, adding at least 38.5 lakh to be provided in the first stage and 16.5 lakh in the second stage. …
Read More...

Haryana: Haryana Home Minister Anil Vij Thursday said he has volunteered to take the trial dose of Covaxin, India’s first indigenous Covid-19 vaccine candidate. The minister will take the trial dose on Friday at 11 am at Civil Hospital,…
Read More...

Bhubaneswar: Human clinical trials of the country's indigenously developed Covid-19 vaccine is set to begin this week at a Bhubaneswar-based institute one of the 12 centres selected by the ICMR for conducting phase one and two of the…
Read More...

Bengaluru: In a rather positive development amid the pandemic situation, Hyderabad-bassed Bharat Biotech has begun the human trials of COVAXIN, India’s first indigenous vaccine candidate the coronavirus infection, and all three subjects so…
Read More...